Artiklar med krav på offentlig åtkomst - Vandhana Muralidharan-ChariLäs mer
Tillgängliga någonstans: 6
Microvesicles: mediators of extracellular communication during cancer progression
V Muralidharan-Chari, JW Clancy, A Sedgwick, C D'Souza-Schorey
Journal of cell science 123 (10), 1603-1611, 2010
Krav: US National Institutes of Health
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles
V Muralidharan-Chari, J Clancy, C Plou, M Romao, P Chavrier, G Raposo, ...
Current Biology 19 (22), 1875-1885, 2009
Krav: US National Institutes of Health
Regulated delivery of molecular cargo to invasive tumour-derived microvesicles
JW Clancy, A Sedgwick, C Rosse, V Muralidharan-Chari, G Raposo, ...
Nature communications 6 (1), 6919, 2015
Krav: US National Institutes of Health
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo
V Muralidharan-Chari, H Hoover, J Clancy, J Schweitzer, MA Suckow, ...
Cancer research 69 (6), 2201-2209, 2009
Krav: US National Institutes of Health
Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells
V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, ...
Oncotarget 7 (31), 50365, 2016
Krav: US National Institutes of Health
Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
O Abdulmalik, NHE Darwish, V Muralidharan-Chari, MA Taleb, SA Mousa
haematologica 107 (2), 532, 2021
Krav: US National Institutes of Health
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.